tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
Holding PCRX?
Track your performance easily

Pacira Pharmaceuticals (PCRX) Financial Statements

353 Followers

Pacira Pharmaceuticals Financial Overview

Pacira Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.051; its P/E ratio is -8.15; Pacira Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $0.78. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 168.57M$ 178.02M$ 167.12M$ 181.24M$ 163.93M
Gross Profit$ 129.71M$ 133.76M$ 119.70M$ 133.55M$ 124.18M
EBIT$ -134.17M$ 40.47M$ 18.86M-$ 19.38M
EBITDA$ -113.05M$ 60.12M$ 37.99M-$ 37.81M
Net Income Common Stockholders$ -143.47M$ 18.89M$ 8.98M$ 24.87M$ 10.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 453.81M$ 404.23M$ 325.89M$ 278.58M$ 235.19M
Total Assets$ 1.52B$ 1.65B$ 1.58B$ 1.57B$ 1.53B
Total Debt$ 644.42M$ 648.60M$ 581.78M$ 586.04M$ 590.30M
Net Debt$ 190.61M$ 244.37M$ 255.89M$ 307.46M$ 355.11M
Total Liabilities$ 772.11M$ 767.54M$ 691.16M$ 704.26M$ 702.91M
Stockholders Equity$ 749.58M$ 879.28M$ 892.16M$ 870.13M$ 831.55M
Cash Flow-
Free Cash Flow$ 49.83M$ 51.65M$ 46.27M-$ 41.04M
Operating Cash Flow$ 53.92M$ 53.24M$ 49.10M$ 47.58M$ 44.44M
Investing Cash Flow$ -52.16M$ -15.21M$ -15.53M$ 8.37M$ -4.34M
Financing Cash Flow$ -2.85M$ 24.98M$ -2.82M$ -1.78M$ -27.79M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

Pacira Pharmaceuticals Debt to Assets

Pacira Pharmaceuticals Cash Flow

Pacira Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis